Technology
Health
Pharmaceutical
Hookipa Pharma Inc
$7.289876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$7.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.29 (4.15%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell HOOK and other stocks, options, ETFs, and crypto commission-free!
About HOOK
HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary its arenavirus platform that is designed to reprogram the body's immune system. Its product include VaxWace, a replication-deficient viral vector; and TheraT, a replication-attenuated viral vector, are designed to induce robust antigen specific CD8+ T cells and pathogen-neutralizing antibodies. Read More The company was founded by Rolf Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel Pinschewer in 2011 and is headquartered in New York, NY.
CEO
Employees
56
Headquarters
New York, New York
Founded
2011
Market Cap
157.17M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
46.44K
High Today
$7.28
Low Today
$6.83
Open Price
$7.00
Volume
27.65K
52 Week High
$14.76
52 Week Low
$6.06
Collections
Technology
Health
Pharmaceutical
2019 IPO
US
North America
Price Paid on Robinhood
48% Lower
Right Now
52 Week Low
$13.71
Average Price Paid
$13.93
52 Week High
$14.76
HOOK Earnings
-$0.63
-$0.59
-$0.55
-$0.51
Q2 2019
Estimated
-$0.51 per share
Actual
-$0.63 per share